STOCKS TELEGRAPH

Author: ST Staff

  • Why Is TRxADE (MEDS) Stock Skyrocketing Today, Spiking More Than 100%?

    At start of the trading today, shares of integrated drug procurement, delivery, and healthcare platform TRxADE HEALTH Inc. (MEDS) rose 112.26% to $9.36 at the time of this writing.

    TRxADE closed Wednesday’s session at $4.42, down 3.07 percent. MEDS shares traded at 0.28 million, a lower volume than the daily average of 4.26 million shares traded over the last 50 days. In the past year, MEDS share prices have fallen -26.33%, and this week they have declined -4.74%.

    MEDS stock has lost -15.65% over the past three months, while it has lost -18.30% over the past six months. As of June 30, MEDS had an outstanding share count of 8.09 million while its market value was $34.74 million. As its subsidiary launches a new program, the MEDS stock has gained traction.

    What was that program about?

    In the United States, TRxADE is a health services IT company dedicated to optimizing the prescription journey, drug procurement, and patient engagement through technology. TRxADE is a leading drug purchasing marketplace operated by MEDS, providing price transparency to 12,100+ members nationwide. A variety of telehealth services are offered by MEDS under the Bonum Health brand.

    TRxADE Bonum Health, TRxADE’s Digital Health business subsidiary, has signed a deal with Big Y Pharmacy and Wellness Centers in Massachusetts and Connecticut to distribute Telemedicine services.

    • Using Bonum Health’s mobile health services and prescriber program, staffed by more than 600 board-certified medical providers, Big Y pharmacies will be able to provide their patients with affordable telemedicine.
    • The partnership also offers Bonum Health prescription discount savings to Big Y patients.
    • and Connecticut see increasing numbers of uninsured and underinsured consumers, and consumers are clamoring for more affordable healthcare options.
    • Big Y entered into the collaboration to enhance its collaborative care network and to expand its digital healthcare offerings.
    • And Bonum Health could contribute to Big Y’s diversification of digital healthcare in-store and at the community level.
    • Through Bonum’s mobile application, Big Y pharmacies will be able to utilize a turnkey Telemedicine and prescription savings tool.
    • Furthermore, Big Y pharmacy leadership saw an opportunity to offer their patients deeply discounted, low-cost care through Bonum.
    • Additionally, Bonum Health will be expanding Big Y’s prescription discounts, using Bonum’s digital platform, for which Big Y has chosen Bonum Health.

    MEDS’ other development:

    MedCheks, another subsidiary of TRxADE, has recently launched the Health Passport app for iOS devices. With the MedCheks app, one can securely show medical records, such as vaccination records and test results, to gain entrance to a country, establishment, event or mode of transportation that requires proof of health. As COVID-19 subsides in certain markets, TRxADE HEALTH (MEDS) addresses the market need for cost-effective, advanced digital health applications to accelerate the reopening of the economy.

  • POETF Stock Rose Nearly 14%. How Did That Happen?

    Yesterday, POET Technologies Inc (OTCQX: POETF) reached a price of $1.1525, up 13.75%. A total of 2.30M shares of POET Technologies stock were traded versus its average weekly volume of 881.40K. POET Technologies’ share price rose, despite no current news, which makes it easier to examine recent developments in greater depth.

    What has been happening at POETF lately?

    The POET Optical Interposer is a new platform developed by POET Technologies that offers integration solutions. By combining advanced semiconductor manufacturing techniques and packaging methods with electronic and photonic devices, POETF is able to seamlessly integrate both into a single multi-chip module. By replacing costly components with POETF’s Interposer, conventional photonics eliminates labor-intensive assembly, alignment, burn-in, testing, and maintenance procedures. Any device or system that integrates electronics and photonics can benefit from the cost-efficient integration scheme and scalability of the POETF Optical Interposer.

    The O-band LightBar product from POET Technologies will be available for samples beginning in September, announced the company earlier this month.

    • In applications requiring remote and aligned light sources, the POET LightBar products enable co-packaging of electronics and photonics.
    • Among other applications, POETF’s products are used for data center switches, optical computing, and various sensing devices.
    • Using a POETF LightBar remote light source in data processing will allow for more effective control of laser heat.
    • Lasers, which are more likely to fail than other components, can also be replaced on-site with remote light sources.
    • The LightBar of the POETF operates as a key element of sensing and computing in which both photonic and electronic elements interact in a miniature, self-contained system.
    • In addition to adopting all of the intrinsic features of POETF’s products, LightBar products incorporate integrated spot-size converters that reduce coupling losses and boost laser efficiency.
    • A virtual exhibition held at the Optical Fiber Communication (OFC) Conference earlier this month featured live demonstrations of POETF products.

    POET Technologies also announced that samples of its 100G and 200G CWDM4 Optical Engines would be available early in July. The POETF’s Optical Engines are embedded with four flip-chipped 28G PAM4 CWDM DFB (distributed feedback) lasers, as well as 28G detectors, monitor photodiodes, and bonding pads.

    POETF’s other plans:

    With the QSFP28 module, POETF Optical Engines are compatible with the MSA (Multi-Source Agreement) standards for transmitting only, receiving only or transmitting and receiving in a single compact chip less than 60mm square. Eventually, POETF will also offer 400G transmission and reception optical engines in DR4 and FR4. September will see the availability of samples of the receive optical engine by POETF.

  • What Caused The ISWH Stock To Rise 28% Last Session?

    As of yesterday’s close, shares of ISW Holdings Inc (OTCPink: ISWH) were up 28.28% to $0.4700. There were 2.02 million shares traded in ISW Holdings stock compared to 724.29K average weekly shares. ISWH stock gained after the company provided hashrate data and revenue expectations.

    What has ISWH shared?

    Nevada-based ISW Holdings is a diversified portfolio company that serves consumer product demands with essential business lines. With its proprietary procurement process, ISWH can develop strategic brand identities, facilitate early growth, and facilitate team management. The ISWH seeks to work with its partners to build a scalable platform that meets the needs of large markets.

    Various strategic innovative methods make ISWH capable of meeting these needs. Brands are created and managed by ISWH across a range of disruptive industries. By guiding its proprietary companies through critical stages of market development, such as conceptualization, go-to-market strategies, engineering, and production integration, ISWH is able to optimize distribution and product quality.

    ISW Holdings together with Bit5ive, LLC (“Bit5ive”) recently provided an update about the Company’s growing operations as it expands and optimizes its cryptocurrencies mining capacity.

    • With a current market capitalization of $25 million, ISWH has been growing expertise in cryptocurrency, and telehealth allows it to acquire assets in these sectors, launch them, host them, and operate them.
    • Partnering with Bit5ive has enabled ISWH to create an advanced POD5 mining infrastructure as well as the capacity to expand its mining operations.
    • Over the coming months, ISWH plans to expand and optimize its offerings in this domain.
    • Currently, ISWH is utilizing energy resources to operate its mining equipment in Kennerdell, Pennsylvania.
    • With a Bitmain Antminer s17 fleet that is already online and working, ISWH is expected to generate $484,000 in monthly revenue – or over $5.8 million annually – through the upgrade to 72,000 T/s of its hashrate.
    • ISWH should experience a reduction in proportional direct mining costs as it continues to increase its hashrate.
    • As a result, ISWH continues to rely on Bit5ive to deliver expertise and support to translate its investment in this process into growing value for ISWH members.
    • With Bit5ive, the largest provider of collective management services and mining equipment in North America, ISWH has developed a turnkey solution to provide cost-efficient and reliable hosting, distribution of mining equipment, and installation and management of mining pools.

    Other mining teams to be explored by ISWH:

    ISW Holdings (ISWH) and Bit5ive are also exploring new opportunities to expand through acquisitions and possible partnerships. ISWH will have the privilege of meeting many other mining teams, projects, and companies associated with crypto in Miami’s Mining Disrupt and Expo Conference scheduled for July 20-21.

  • What Drove The GDET Stock Up 29% During Last Trading?

    The market capitalization of GD Entertainment & Technology Inc (OTCPINK:GDET) climbed by 29.17% to $13.86M after closing at $0.0031 during the previous session. GDET stock traded 2.37B shares recently, greater than its average daily volume of 187.29M. Additionally, GDET stock has traded between $0.0029 and $0.0043 over the past session. GDET has a float of 357.54M shares versus 4.47B outstanding shares. Launch of dual crypto cards boosts GDET stock price.

    GDET has launched what?

    The focus of GD Entertainment & Technology is on high-growth industries and offering a wide array of premium products throughout the world. A GDET subsidiary, DreamCard, offers a high-end metal debit and credit card, which can be customized for a fee. With DreamCard, users can customize a debit or credit card using GDET’s state-of-the-art online platform, as well as create customized Specialty Cards for Customer Loyalty and Affinity Networks. By using Dreamcards, GDET lets the cardholder design a new metal, 24karat or stainless steel card made according to the cardholder’s specifications and ship it to the customer. GDET is used primarily in casinos and by affinity networks.

    The world’s first Crypto/Fiat Dual Debit/Credit Card featuring a dual-chip and made of highly polished metal has just been launched by GDET.

    • In addition to storing their Crypto on “Cold Storage”, Dual Crypto Dreamcard users may also access their wallet using the Fiat functionality of the card.
    • A user can access multiple accounts from anywhere with the Dual Crypto Dreamcard from GDET.
    • GDET’s Dual Crypto Dreamcard provides the first-to-market functionality of a burgeoning market for this type of functionality, just in time for other venues and vendors to accept this technology.
    • In addition, GDET has revamped its DreamCard website.
    • Customers can use this site to replace their plastic debit or credit card securely with a high-quality card, available in lustrous metal colors with multiple design options or glistening 24-karat gold designs based on preference.
    • In some circumstances, DreamCard staff will permit users to design their own original card design to be used on the card utilizing GDET’s newly launched website.
    • In the words of GDET, the process can be followed easily, is user friendly, and is becoming popular across a range of demographics.

    What will GDET do with this opportunity?

    GDET’s Dreamcard designed a prototype card specifically for MGM Grand Casino and is planning to pitch this to the casino through their hired Casino Consultant as part of a highly targeted branding effort. A percentage of the sale of each card is contributed to GDET, which may in turn be used to increase marketing effectiveness for certain Internet Influencers.

  • Orchard Therapeutics plc (ORTX) Stock on the Rise Following Collaboration with Pharming Group

    Orchard Therapeutics PLC (ORTX) stock prices were down by a marginal 2.44% as of the market closing on June 30th, 2021, bringing the price per share down to USD$4.39 at the end of the trading day. Subsequent pre-market fluctuations saw the stock surge by 8.66%, bringing it up to USD4.77.

    Collaboration with Pharming

    July 1st 2021 saw the company announce its strategic collaboration with Pharming Group N.V. to research, develop, manufacture, and commercialize OTL-105. The newly disclosed investigational ex vivo autologous hematopoietic stem cell (HSC) gene therapy is designed to treat hereditary angioedema (HAE), which is a rare disorder that causes recurring swelling attacks in the face, throat, extremities, and abdomen and can be fatal.

    OTL-105

    The investigational HSC gene therapy OTL-105 is designed to prevent hereditary angioedema attacks by increasing C1 esterase inhibitor (C1-INH). It inserts one or more functional replicas of the SERPING1 gene into the HSCs of patients ex vivo, which are then transplanted back into the patient for suitable durable C1-INH production. Preclinical studies to date have seen the treatment demonstrate high levels of SERPING1 gene expression via lentiviral-mediated transduction in multiple cell lines and primary human CD34+ HSCs.

    Details of the Agreement

    As per the terms of the agreement, Pharming has been granted worldwide rights to OTL-105 after having been also given the responsibility for its clinical development, regulatory filings, and commercialization of the investigational gene therapy, which will include covering associated costs. ORTX will oversee the completion of IND-enabling activities as well as the manufacturing of the treatment during pre-clinical and clinical development, with the funding being provided by Pharming. Furthermore, both companies will collaboratively explore the application of non-toxic conditioning regimen for use in tandem with OTL-105 administration.

    Financial Details

    The company will be given an upfront payment of USD$17.5 million, which will consist of USD$10 million in cash and USD$7.5 million equity investment from Pharming. The equity investment will include a premium to the company’s recent share price. ORTX is also eligible to receive up to USD$189.5 million in regulatory, development, and sales milestones, as well as royalty payments on future worldwide sales in the range of mid-single to low double-digits.

    Future Outlook for ORTX

    Armed with the recent collaboration that is likely to expand the scope of ORTX’s operations over the future, the company is poised to capitalize on the increased opportunities afforded to it. Investors are hopeful that company will be able to continue its trajectory of success and usher in unprecedented growth.

  • Telcoin (TEL) coin upcoming resistance at $0.052

    Telcoin (TEL) coin upcoming resistance at $0.052

    Telcoin (TEL) peaked at $0.059 in the beginning of May. In par with the market, Telcoin also began declining sharply as the market crashed. After falling to a low of $0.021, Telcoin has somewhat recovered. At the time of writing, the cryptocurrency stands at a price of $0.025. The price has been moving upwards in the past twenty-four hours while the trading volume has shot up by 150%.

    Telcoin (TEL) Technical Analysis

    The market sentiment for the cryptocurrency is neutral as the bulls and the bears are fighting over dominance. Out of the total twenty-six technical indicators, nine are standing at a buy position while eight are indicating a sell position and nine are neutral. The oscillators are bullish and the moving averages are bearish.

    Telcoin (TEL) Technical Analysis
    Telcoin (TEL) Technical Analysis

    Telcoin has been operating in a broadening ascending channel formation. The cryptocurrency had touched the upper boundary of the channel during the bull run while it is currently at the lower boundary – testing the support level. Telcoin is expected to bounce back from the lower boundary of the channel establishing it as strong support. If the support is established then the cryptocurrency will reach upwards towards the weekly resistance level at $0.52. The strength of the bullish momentum will determine the upcoming price movements of the cryptocurrency.

    Telcoin (TEL) Price Prediction

    The price predictions for the coin are bullish. The cryptocurrency is expected to continue to grow in the longer timeframes. Wallet Investor’s projections places the cryptocurrency at a price of $0.050 after a year while the 5-year forecast predicts Telcoin to be operating at $0.16. Digital Coin Price predictions are also favorable for the cryptocurrency. Per the estimates, Telcoin will end the current year with a price of $0.039 while the price in 2028 is expected at $0.11.

  • Alterity Therapeutics Ltd. (ATHE) Stock Skyrockets as Meme Stock Phenomenon Continues to Proliferate Stock Exchange

    Alterity Therapeutics Ltd. (ATHE) stock prices were down by 1.52% as of the market closing on June 30th 2021, bringing the price per share down to USD$1.30 at the end of the trading day. Subsequent pre-market fluctuations saw the stock skyrocket by a massive 66.92%, bringing it up to USD$2.17.

    EMA Guidance

    June 23rd, 2021 saw the company announce guidance it had received from the European Medicines Agency (EMA) in regard to key aspects of ATHE’s Phase 2 clinical trial for the treatment of Multiple System Atrophy (MSA) with its investigational drug ATH434. The company is actively preparing for the impending launch of the Phase 2 trial, which is scheduled to commence in the second half of 2021.

    About the EMA

    The EMA is an agency with jurisdiction in the European Union, with the responsibility of evaluating and supervising medicinal products. The agency plays a crucial role in the timely support of the sound development of high-quality, effective, and safe medicines for the treatment of respective patients. With their advice not being binding, the EMA influences improved trial designs to facilitate more robust and complete data in the evaluation of treatments.

    Scope of ATH434

    With MSA affecting a sizeable portion of the U.S population and the absence of any approved treatments for MSA, the scope of ATH434 is extensive. There is no regulatory precedence for defining clinical endpoints or guiding patient enrollment, thus requiring greater consideration in developing a trial design that is most suitable. Accordingly, the company has recruited clinical experts and global regulatory authorities for input. ATHE is also conducting BioMUSE, a natural history study designed to identify biomarkers and clinical endpoints most appropriate to capture efficacy signals in the Phase 2 study.

    Meme Stock Phenomenon

    Despite the promising development of the course of the ATH434 trial, the recent surge in ATHE’s stock price seems unmerited. Such drastic movement in the absence of news coverage or changes in fundamentals likely signals the company having been the latest target of the meme stock phenomenon that has resurged in the stock market. Driven by Reddit-based retail investors, underperforming companies with high short interest are selected for a coordinated short squeeze.

    Future Outlook for ATHE

    Armed with the recent surge in its equity value, ATHE finds itself with a fortuitous influx of resources to leverage in order to ensure more organic growth. Investors are hopeful that the company will manage to use the resources at its disposal to continue its trajectory of success.

  • Staffing 360 Solutions, Inc. (STAF) Stock Skyrockets Following Announcement of Reverse Stock Split

    Staffing 360 Solutions, Inc. (STAF) stock prices were down by 7.43% as of the market closing on June 30th, 2021, bringing the price per share down to USD$0.5744 at the end of the trading day. Subsequent pre-market fluctuations saw the stock skyrocket by a staggering 552.86%, bringing it up to USD$3.75.

    Reverse Stock Split

    June 30th, 2021 saw the company announce its intent to implement a reverse stock split of its common stock at a ratio of 6 pre-split shares being consolidated into 1 post-split share. The stock split went into effect at 5:00 pm EDT on June 30th, 2021, with the company’s shares continuing to be traded on the NASDAQ Capital Market under the STAF ticker symbol. The shares will begin trading on a split-adjusted basis when the market opens on July 1st, 2021.

    Details of the Reverse Split

    The company’s Board of Directors were authorized to effect a reverse stock split on June 21st, 2021 at a special meeting of stockholders, with the amendment to the Certificate of Incorporation allowing for a ratio of at least 1-for-2 and not more than 1-for-20. While the stock split will not affect the percentage interest of any stockholder in the company’s equity, there will be cases where stockholders will own a fractional share. In such cases, the share will be rounded up to the nearest whole number of shares. The number of common stock outstanding will go from 39,166,528 to 6,527,755.

    Loan Forgiveness

    The company recent reported having been granted full forgiveness by the Small Business Administration for the USD$10 million Paycheck Protection Program loan. The loan was given to Monroe Staffing Services, LLC, an indirect wholly owned subsidiary of STAF. Since, the company has applied for further forgiveness of USD$9.4 million in PPP loans, with management confident in their being written off. Cumulatively, STAF has achieved a 55% reduction in its debt over the past year.

    Q2 2021 Financial Reports

    STAF forecasts financial reports for Q2 2021, ended July 3rd, 2021, to indicate roughly 20% year-over-year growth in revenue up to USD$52 million. Gross profits for the quarter are also expected to be up by 20%, with reports of USD$457,000 in operating profit as compared to USD$1.5 million operating loss in Q2 2020.

    Future Outlook for STAF

    With the drastic change seen by its stock price as a result of the reverse stock split, STAF is poised to capitalize on its continued listing on the Nasdaq Capital Market. Investors are hopeful that management will continue to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • Why Did Cuentas (CUEN) Stock Surge In Premarket Session?

    Cuentas Inc. (CUEN) has rose 4.34% at $6.49 in the premarket session on the last check today. CUEN stock gained 123.74% to reach $ 6.22 in the last trading session. CUEN stock ranged between $ 5.80 and $ 9.25 in the last trading session.

    A total of 208.96 million shares of CUEN stock changed hands, compared to its daily average of 0.17M shares over 100 trading days. Within the last five days, shares of CUEN have risen 184.02%, while in the last month they have risen 174.01%.  CUEN stock has been on the rise after doubling its value in previous sessions.

    How did CUEN more than double its value?

    A FinTech service provider with a mission to provide solutions to the unbanked and underbanked Hispanic and Latino community, Ceuntas provides e-banking solutions and e-commerce services. CUEN offers a variety of services, including mobile banking, online banking, mobile deposits, prepaid debit, ACH, and a cash remittance program. It also provides peer to peer money transfers and bank accounts to clients who were unable to acquire bank accounts previously.

    The world’s first shared WiFi network, WaveMax Corporation, was selected by TelcoDR as part of their showcase of the most innovative mobile technology during Mobile World Congress in Barcelona.

    • As part of its collaboration with Cuentas (CUEN), WaveMAX will show off the world’s first WiFi6-5G shared network coming soon to New York.
    • Using WaveMax’s SharedFi technology, small cells and WiFi access points can be shared.
    • If the user opts in to be impacted by location-based advertising, he/she gains access to this shared network.
    • WaveMAX advertiser dashboards are used to customize ads so that they are targeted to the right audience, at the right time, and in the right place.
    • CUEN has signed a contract to roll out SharedFi at 170 test sites in the New York City-Tristate area.
    • CUEN plans to install 1,000 new “Bodega Stores” in a 50/50 joint venture with WaveMAX if the 6 month test is successful.
    • In addition to the automatic connection to WiFi6, customers will receive special offers inside the Bodega store to enhance their shopping experience.
    • Customers will also receive product discounts via the Cuentas Mobile App and promotional offers for the Cuentas GPR card.

    CUEN’s other agreements:

    Cuentas (CUEN) recently signed a Marketing Agreement with SDI Black 011 (SDI), one of the larger prepaid telecommunications companies, to incorporate multiple products for sale. CUEN will integrate Cuentas Prepaid Mastercard, Cuentas Mobile App and digital wallet into its electronic portal, while SDI will be able to expand the SDI distribution network through CUEN. CUEN will deposit $200,000 in escrow to jump start the SDI network expansion, initially in New York, New Jersey, Connecticut tri-state area to sign up 1,000 new targeted prime locations in the United States.

  • Bridgeline Digital, Inc. (BLIN) Stock Skyrockets as Latest Target of Meme Stock Phenomenon

    Bridgeline Digital, Inc. (BLIN) stock prices were up by a massive 26.84% as of the market closing on June 30th, 2021, bringing the price per share up to USD$4.30 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 25.58%, bringing it up to USD$5.40.

    Unbound CMS Contract

    June 22nd 2021 saw the company announced the signing of a long-term contract of Unbound CMS with one of the largest haircutting franchises in the U.S. With more than 1800 locations across the U.S., the customer has been a long term client with Unbound CMS since 2021, when their corporate site was designed and built by the Unbound Team. Over the years, Unbound integrated store locators and developed franchisee local sites, with each Unbound-powered franchise site having its own unique URL with webpages for each location.

    Unbound Merits

    The company made moves recently to consolidate the network of franchises under the main domain, hoping to streamline the overall digital experience, while also reducing costs over the long term. After market research into evaluating CMS options, Unbound was recognized as the most appropriate solution for the project. As per a key part of the closing of this franchise-specific renewal deal, Unbound will facilitate the provision of a powerful Local Pages solution. The contract to develop and implement the new digital strategy is set to last 36 months.

    Q2 2021 Financial Reports

    Total revenue for the second quarter of fiscal 2021, ended March 31st 2021, was reported at USD$2.9 million, up from the USD$2.7 million reported for the prior year period. With total revenue consisting of Licenses and Services revenue, the former exhibited 8% growth, while the latter grew by 2%. Gross profits were also up, by 16% up to USD$1.8 million for the quarter ended March 31st 2021, comparable to the USD$1.6 million reported in the prior year period.

    Meme Stock Phenomenon

    Despite these promising developments over the quarter, there has been no news coverage or change in the fundamentals of BLIN to justify the meteoric rise it has seen lately. It seems very likely that the company is fortuitously finding itself to be the next target of the meme stock phenomenon that has been taking over stock markets as of late. Driven by retail investors who use the social media platform Reddit, this phenomenon sees underperforming stocks with high short interests get pumped by a coordinated short squeeze.

    Future Outlook for BLIN

    Despite being rife with volatility on the basis of there not being sound reasons to invest in a company based on its merit, the activity affords BLIN extensive opportunities as it sees its equity value skyrocket. Investors are hopeful that the company will make moves to maintain the momentum generated by the Reddit-driven investor community.